Calli Biotech is an Australian biopharmaceutical company dedicated to developing innovative cancer therapies, bringing together the power of the immune system and the induction of apoptosis to generate improved patient outcomes.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (7 years)
Address:
ADELAIDE, AU
LOW
spending power
